GLP1s: Have we cured obesity by inducing frailty?

Join Professor Danny Green, University of Western Australia, to briefly discuss early cardiovascular disease detection and optimized prevention through interventions targeted at the earliest modifiable stages of CV disease.

The talk will focus on chronic disease prevention using incretin drugs combined with personalized exercise to optimize and modify body composition, and big picture strategies to address societal challenges, addressing the supply/demand dynamics for chronic disease prevention in healthcare systems.

Bio

Danny is a Winthrop Professor in the School of Human Sciences (Sport and Exercise Science) at The University of Western Australia. He is a cardiovascular exercise physiologist specializing in chronic disease prevention. His research spans all ages, from preventing atherosclerosis in obese youth to optimizing exercise and medication for heart disease, stroke, diabetes and heart failure. His research teams in Australia and the UK have published over 400 peer-reviewed papers, including Lancet, Circulation, JACC, Physiological Reviews, funded by over 50 nationally competitive grants in both countries. He leads UWA’s Cardiovascular Research Group, which develops early disease detection and personalized prevention strategies through transdisciplinary collaborations in science, engineering, and medicine. He is also Foundation Director of the UWA Healthspan Institute, which coordinates clinical, research and community engagement of allied health and prevention agendas across the University. Through advocacy, policy and political engagement, he pioneered Clinical Exercise Physiology in Australia and the UK, which resulted in the recognition of new allied health professions, acceptance in Medicare and the NHS, government rebates for service, establishment of peak accreditation bodies, and development of sector-wide university-accredited curricula.